Company Filing History:
21 out of 3,688 
19 out of 53 
Years Active: 2015-2024
Title: Elizabeth M Enlow: Revolutionizing Drug Delivery with Nanocrystals
Introduction:
Elizabeth M Enlow, based in Waltham, MA, is a groundbreaking inventor and researcher specializing in the development of nanocrystals for drug delivery systems. With an impressive list of patents and a successful career in renowned companies, Enlow has made significant contributions to the field by enhancing particle transport in mucus barriers. This article will delve into Enlow's latest patents, career highlights, notable collaborations, and the impact of her innovations on the pharmaceutical industry.
Latest Patents:
Enlow's recent patents showcase her expertise in developing nanocrystals and compositions that aid particle transport in mucus. One notable invention involves the creation of mucus-penetrating particles (MPP) without the need for polymeric carriers. By modifying the surface coatings of pharmaceutical agent particles with low water solubility, efficient transportation through mucus barriers can be achieved. These innovations have significant implications for drug delivery, imaging, and diagnostic applications.
Another significant patent focuses on crystalline forms of therapeutic compounds. Enlow's crystalline forms of Compound 3 offer improved pharmaceutical compositions and particles, including mucus-penetrating particles. The invention provides new avenues for treating diseases and preventing ailments using these unique crystalline structures.
Career Highlights:
Elizabeth M Enlow has a remarkable track record, having amassed 36 patents throughout her career. She has made substantial contributions to the field of drug delivery systems, particularly through her work on nanocrystals. Enlow's research has opened doors to more efficient and effective drug administration, paving the way for advancements in various medical applications.
Collaborations:
Enlow's expertise and innovative mindset have led her to collaborate with esteemed individuals in the industry. Notably, she has worked at Kala Pharmaceuticals, Inc., a renowned company dedicated to developing innovative treatments for eye diseases. Enlow's collaborations at Kala Pharmaceuticals have likely yielded remarkable advancements in ocular drug delivery systems.
Additionally, Enlow has affiliations with The Johns Hopkins University, a renowned institution fostering cutting-edge research and innovation. Her association with such prestigious partners undoubtedly contributes to her groundbreaking inventions and advancements in the field.
Conclusion:
Elizabeth M Enlow's groundbreaking work in nanocrystals and drug delivery systems has revolutionized the pharmaceutical industry. With an extensive patent portfolio and collaborations with notable organizations, she continues to push the boundaries of drug delivery technology. Enlow's inventions, such as mucus-penetrating particles and crystalline forms of therapeutic compounds, hold immense promise for various medical applications, from drug delivery to imaging and diagnostics. As an innovator and inventor, Enlow's contributions will undoubtedly shape the future of pharmaceutical advancements, improving patient outcomes and transforming healthcare practices.